While price is key to generic purchasing decisions, additional factors such as supply reliability, unit dose availability, contract status, and product and label quality impact most pharmacies’ purchasing decisions. Shortages continue to affect purchasing and often drive off-contract sourcing. Nevertheless, most facilities are confident that their current budgets will adequately support projected increases in generic spending. Pharmacy directors report that Fresenius Kabi, Pfizer, Major Pharmaceuticals, and Mylan are the leading generic providers by dollar volume.